Michael Maes
Michael Maes
Prof. Dr., Chulalongkorn University, Bangkok, Thailand
Verified email at chula.md - Homepage
TitleCited byYear
Cytokines and major depression
OJG Schiepers, MC Wichers, M Maes
Progress in neuro-psychopharmacology and biological psychiatry 29 (2), 201-217, 2005
12112005
Evidence for an immune response in major depression: a review and hypothesis
M Maes
Progress in Neuro-Psychopharmacology and Biological Psychiatry 19 (1), 11-38, 1995
9351995
The serotonin hypothesis of depression
M Maes
Psychopharmacology: the fourth genration of progress, 933-944, 1995
8931995
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, ...
Neuroscience & biobehavioral reviews 35 (3), 804-817, 2011
8662011
The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety
M Maes, C Song, A Lin, R De Jongh, A Van Gastel, G Kenis, E Bosmans, ...
Cytokine 10 (4), 313-318, 1998
7521998
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
M Maes, R Yirmyia, J Noraberg, S Brene, J Hibbeln, G Perini, M Kubera, ...
Metabolic brain disease 24 (1), 27-53, 2009
7372009
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness
M Maes, P Galecki, YS Chang, M Berk
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (3), 676-692, 2011
7132011
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness
M Maes, P Galecki, YS Chang, M Berk
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (3), 676-692, 2011
7132011
Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
M Maes, E Bosmans, R De Jongh, G Kenis, E Vandoolaeghe, H Neels
Cytokine 9 (11), 853-858, 1997
7011997
Major depression and activation of the inflammatory response system
M Maes
Cytokines, stress, and depression, 25-46, 1999
6781999
Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
M Maes, HY Meltzer, E Bosmans, R Bergmans, E Vandoolaeghe, ...
Journal of affective disorders 34 (4), 301-309, 1995
6551995
So depression is an inflammatory disease, but where does the inflammation come from?
M Berk, LJ Williams, FN Jacka, A ONeil, JA Pasco, S Moylan, NB Allen, ...
BMC medicine 11 (1), 200, 2013
6282013
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the K
B Leonard, M Maes
Neuroscience & Biobehavioral Reviews 36 (2), 764-785, 2012
6002012
Lowered s3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients
M Maes, A Christophe, J Delanghe, C Altamura, H Neels, HY Meltzer
Psychiatry research 85 (3), 275-291, 1999
5581999
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
L Capuron, A Ravaud, PJ Neveu, AH Miller, M Maes, R Dantzer
Molecular psychiatry 7 (5), 468, 2002
4882002
Fatty acid composition in major depression: decreased s3 fractions in cholesteryl esters and increased C20: 4s6C20: 5s3 ratio in cholesteryl esters and phospholipids
M Maes, R Smith, A Christophe, P Cosyns, R Desnyder, H Meltzer
Journal of affective disorders 38 (1), 35-46, 1996
4841996
The new 5-HThypothesis of depression: cell-mediated immune activation induces indoleamine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis K
M Maes, BE Leonard, AM Myint, M Kubera, R Verkerk
Progress in neuro-psychopharmacology and biological psychiatry 35 (3), 702-721, 2011
4452011
Indicators of immune activation in major depression
A Sluzewska, J Rybakowski, E Bosmans, M Sobieska, R Berghmans, ...
Psychiatry research 64 (3), 161-167, 1996
4391996
Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers
M Maes, E Bosmans, J Calabrese, R Smith, HY Meltzer
Journal of psychiatric research 29 (2), 141-152, 1995
4371995
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
M Maes
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (3), 664-675, 2011
4352011
The system can't perform the operation now. Try again later.
Articles 1–20